Moderna Inc is considering pricing its COVID-19 shot at $110 to $130 per dose in the United States when it shifts from government contracting to commercial distribution of the shots, the company's Chief Executive Officer Stephane Bancel told the Wall Street Journal on Monday.
is considering pricing its COVID-19 shot at $110 to $130 per dose in the United States when it shifts from government contracting to commercial distribution of the shots, the company's Chief Executive Officer Stephane Bancel told the Wall Street Journal on Monday.
, adding the company was in discussions with hospital systems, pharmacies and pharmacy-benefit managers to line up distribution of its vaccine ahead of a potential fall booster shot campaign.Moderna did not immediately respond to a Reuters request for comment on the report.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
WSJ News Exclusive | Moderna Considers Price of $110-$130 for Covid-19 VaccineModerna is considering a price of $110-$130 for its Covid-19 vaccine after distribution shifts from government contracting to the commercial market
Lire la suite »
WSJ: Moderna may charge up to $130 per dose of its COVID shotShares of Moderna Inc. were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its...
Lire la suite »
Moderna’s COVID shot to generate $5.0 billion in sales in 2023Shares of Moderna Inc. were up about 1.0% in premarket trading on Monday after the company reiterated that it expects to have $5.0 billion in sales of its...
Lire la suite »
Moderna’s Bancel Prepares for Transition Year as COVID Vaccine Sales Wane(Bloomberg) — Moderna Inc. is looking for potential approval of two new vaccines this year to help compensate for waning sales of its Covid-19 shot, according to Chief Executive Officer Steph…
Lire la suite »
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government's pandemic responseCoronavirus Update: China cracks down on critics of government’s COVID approach
Lire la suite »
The mRNA vaccine technology may hold the key to developing personalized cancer treatmentsAt CES 2023, the CEO of Moderna discusses the development of their COVID-19 vaccine and how to use mRNA technology to create personalized cancer vaccines.
Lire la suite »